Deferred Consent in Pediatric Drug Trials: Moving from Why to How.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 6, p. 533, doi. 10.1007/s40272-021-00480-0
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2021 AND VI 23 AND IP 6
Results: 11
1
2
Acknowledgement to Referees.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 6, p. 529, doi. 10.1007/s40272-021-00479-7
- Publication type:
- Article
3
Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 6, p. 601, doi. 10.1007/s40272-021-00476-w
- By:
- Publication type:
- Article
4
Randomized Clinical Trial of Metoclopramide as Prophylaxis of Gastroesophageal Reflux Disease in Preterm Infants.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 6, p. 591, doi. 10.1007/s40272-021-00475-x
- By:
- Publication type:
- Article
5
Correction to: Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
6
Deferred Consent in Neonatal Clinical Research: Why, When, How?
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 6, p. 565, doi. 10.1007/s40272-021-00473-z
- By:
- Publication type:
- Article
7
Use of Furosemide and Chlorothiazide Combination Continuous Infusion in Furosemide-Refractory Patients in the Pediatric Intensive Care Unit: A Retrospective Cohort Study.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 6, p. 575, doi. 10.1007/s40272-021-00472-0
- By:
- Publication type:
- Article
8
Teriflunomide: Pediatric First Approval.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 6, p. 609, doi. 10.1007/s40272-021-00471-1
- By:
- Publication type:
- Article
9
Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clinical Trials.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 6, p. 583, doi. 10.1007/s40272-021-00470-2
- By:
- Publication type:
- Article
10
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 6, p. 537, doi. 10.1007/s40272-021-00469-9
- By:
- Publication type:
- Article
11
Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 6, p. 549, doi. 10.1007/s40272-021-00468-w
- By:
- Publication type:
- Article